Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New SMA era: A broad-range tiered assessment of function for the evolving SMA phenotype (EVOLVE-SMA).

Journal of neuromuscular diseases - 1 Jul 2026

Moore Burk Meghan, Crawford Thomas O, Johnson Kristen, Apkon Susan, Brown Laurey, Carry Terri, Hoffman Katie, Kelley Carolyn, Kuntz Nancy L, Miller Julie, Nance Jessica, Patel Ruchee, Rao Vamshi, Rothman Carly, Schwaede Abigail, Stratton Anne, Thinger Sara, Trenkle Jessica, Van Os Madeline, Vela Kerry, Duong Tina, Krosschell Kristin J

Abstract excerpt

BACKGROUND: The clinical course of Spinal Muscular Atrophy (SMA) has been transformed by new disease-modifying therapies (DMT). Before DMT, the clinical course of SMA was marked by an inflection point between developmental improvement and degenerative functional losses. The well-established SMA classification by "type" was based upon the age and functional level at which this inflection point manifested....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Child, Preschool

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Muscular Atrophy, Spinal

Share to Phenotype

Share to Reproducibility of Results

Source

Open in PubMed Open full text

Identifiers

PMID: 41467984
DOI: 10.1177/22143602251405346
PMCID: PMC13434954

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New SMA era: A broad-range tiered assessment of function for the evolving SMA phenotype (EVOLVE-SMA).PMID 41467984Read ↗

Decision-making and challenges within the evolving treatment algorithm in spinal muscular atrophy: a clinical perspective.Semantic proximity Read ↗

Refining functional phenotypes in an international cohort of untreated paediatric type 2 and 3 SMA patients using the Revised Hammersmith Scale.Semantic proximity Read ↗

Quality of life data for individuals affected by Spinal Muscular Atrophy: A baseline dataset from the Cure SMA Community Update SurveySemantic proximity Read ↗

Biomarkers in 5q-associated spinal muscular atrophy-a narrative review.Semantic proximity Read ↗

A qualitative, mixed-method approach to reaching consensus on function, fatigue, and fatigability outcomes in teens and adults living with spinal muscular atrophySemantic proximity Read ↗

Dysphagia Phenotypes in Spinal Muscular Atrophy: The Past, Present, and Promise for the Future.Semantic proximity Read ↗

A self-reported Brazilian registry of spinal muscular atrophy: data from natural history, genetic characteristics, and multidisciplinary careSemantic proximity Read ↗

Role Of Rehabilitation in Improving Functional Outcomes Measured by HFMSE In Patients with Spinal Muscular AtrophySemantic proximity Read ↗

Impact of Spinal Muscular Atrophy on Caregivers’ Daily Activities and Health-Related Quality of LifeSemantic proximity Read ↗

Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies.Semantic proximity Read ↗

Development of patient-reported outcome for spinal and bulbar muscular atrophySemantic proximity Read ↗

Identifying Biomarkers of Spinal Muscular Atrophy for Further Development.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.